2009
DOI: 10.4097/kjae.2009.57.3.327
|View full text |Cite
|
Sign up to set email alerts
|

Effect of preoperative administration of celecoxib on postoperative pain after laparoscopic cholecystectomy

Abstract: Background: For laparoscopic cholecystectomy, pain is most frequent complaint and the most common cause of delayed discharge. The aim of this study was to determine the effect of preoperative administration of celecoxib on the level of postoperative pain in patient undergoing laparoscopic cholecystectomy.Methods: We enrolled 60 patients ASA class I and II, scheduled for elective laparoscopic cholecystectomy. The patients were randomized to receive celecoxib 200 mg, celecoxib 400 mg or placebo two hour before t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…32 Prostaglandin synthesis inhibitors, such as diclofenac and cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs, reduce postoperative pain following laparoscopic cholecystectomy, but do not sufficiently control pain. 25…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…32 Prostaglandin synthesis inhibitors, such as diclofenac and cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs, reduce postoperative pain following laparoscopic cholecystectomy, but do not sufficiently control pain. 25…”
Section: Discussionmentioning
confidence: 99%
“…Opioid drugs are useful in relieving postoperative pain, but are associated with a high risk of side-effects. 17,20 Nonopioid alternatives include lidocaine, magnesium, 24 diclofenac and celecoxib, 25 all of which have been used to treat postoperative pain following laparoscopic cholecystectomy. Lidocaine can be administered during the perioperative period to control central hyperalgesia, and affects mechanoinsensitive nociceptors, provides anti-inFammatory effects to sodium channel blockade [26][27][28] and inhibits N-methyl-D-aspartate (NMDA) receptors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Of the included trials, 89 did not mention SAEs, 28–116 and two trials mentioned potential SAEs without specifying in which intervention group these events occurred 117,118 . Lack of response to email inquiries meant these studies could not provide relevant or quantifiable data for any of our outcomes.…”
Section: Resultsmentioning
confidence: 99%